Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) Shares Outstanding (Weighted Average) (2022 - 2023)

Lexeo Therapeutics' Shares Outstanding (Weighted Average) history spans 2 years, with the latest figure at $1.6 million for Q3 2023.

  • For Q3 2023, Shares Outstanding (Weighted Average) fell 1.46% year-over-year to $1.6 million; the TTM value through Sep 2023 reached $1.6 million, down 1.46%, while the annual FY2022 figure was $1.6 million, N/A changed from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2023 was $1.6 million at Lexeo Therapeutics, roughly flat from $1.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $1.6 million in Q3 2022 and bottomed at $1.6 million in Q1 2023.